Publikationen von Alex Sigal
Alle Typen
Zeitschriftenartikel (32)
2022
Zeitschriftenartikel
Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature (2022)
Zeitschriftenartikel
22 (5), S. 267 - 269 (2022)
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT. Nature Reviews Immunology
Zeitschriftenartikel
39 (2), 110650 (2022)
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells. Cell Reports
Zeitschriftenartikel
13 (1), 1976 (2022)
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage. Nature Communications
Zeitschriftenartikel
22, S. 267 - 269 (2022)
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nature Reviews Immunology
Zeitschriftenartikel
602, S. 654 - 656 (2022)
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature
Zeitschriftenartikel
30 (2) (2022)
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host & Microbe
Zeitschriftenartikel
603 (7902), S. 706 - 714 (2022)
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature
Zeitschriftenartikel
603, S. 488 - 492 (2022)
T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature
Zeitschriftenartikel
Milder disease with Omicron: is it the virus or the pre-existing immunity? Nature Reviews Immunology (2022)
2021
Zeitschriftenartikel
12, 757134 (2021)
Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response. Frontiers in Microbiology
Zeitschriftenartikel
4 (1) (2021)
Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology. Commun Biol.
Zeitschriftenartikel
10, e67397 (2021)
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave. eLife
Zeitschriftenartikel
9, e1009871 (2021)
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy. PLoS Pathogens
Zeitschriftenartikel
Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave. Clinical Infectious Diseases, ciab758 (2021)
Zeitschriftenartikel
12 (1) (2021)
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nature Communications
Zeitschriftenartikel
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. eLife, e69317 (2021)
Zeitschriftenartikel
384 (20), S. 1885 - 1898 (2021)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. The New England Journal of Medicine: NEJM / Publ. by the Massachusetts Medical Society
Zeitschriftenartikel
593 (7857), S. 142 - 146 (2021)
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature
Zeitschriftenartikel
184 (9), S. 2372 - 2383 (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell